Legal & General Group PLC Global Blood Therapeutics, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $46,818 - $98,520	1,445 Added 2.62%	56,676 $3.86 Million
Q2 2022 Aug 22, 2022	BUY	$22.3 - $37.39 $80,614 - $135,164	3,615 Added 7.0%	55,231 $1.76 Million
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $49,254 - $68,261	1,918 Added 3.86%	51,616 $1.79 Million
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $10,582 - $17,110	-425 Reduced 0.85%	49,698 $1.46 Million
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $297,606 - $436,131	11,680 Added 30.38%	50,123 $1.28 Million
Q2 2021 Aug 12, 2021	SELL	$32.46 - $43.42 $60,180 - $80,500	-1,854 Reduced 4.6%	38,443 $1.35 Million
Q1 2021 May 17, 2021	BUY	$38.94 - $50.85 $147,154 - $192,162	3,779 Added 10.35%	40,297 $1.64 Million
Q4 2020 Feb 12, 2021	SELL	$37.65 - $63.77 $436,024 - $738,520	-11,581 Reduced 24.08%	36,518 $1.58 Million
Q3 2020 Nov 13, 2020	SELL	$52.76 - $74.49 $11,818 - $16,685	-224 Reduced 0.46%	48,099 $2.65 Million
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $676,421 - $1.14 Million	13,881 Added 40.3%	48,323 $3.05 Million
Q1 2020 May 14, 2020	SELL	$41.72 - $87.2 $108,388 - $226,545	-2,598 Reduced 7.01%	34,442 $1.76 Million
Q4 2019 Feb 13, 2020	BUY	$45.7 - $81.86 $316,244 - $566,471	6,920 Added 22.97%	37,040 $2.94 Million
Q3 2019 Nov 13, 2019	BUY	$45.35 - $57.91 $156,638 - $200,021	3,454 Added 12.95%	30,120 $1.46 Million
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $206,244 - $248,160	3,921 Added 17.24%	26,666 $1.4 Million
Q1 2019 May 15, 2019	BUY	$39.99 - $53.48 $38,630 - $51,661	966 Added 4.44%	22,745 $1.2 Million
Q4 2018 Feb 15, 2019	BUY	$31.54 - $46.67 $117,139 - $173,332	3,714 Added 20.56%	21,779 $894,000
Q3 2018 Nov 20, 2018	BUY	$38.0 - $51.1 $74,974 - $100,820	1,973 Added 12.26%	18,065 $686,000
Q2 2018 Aug 10, 2018	BUY	$38.7 - $50.15 $30,689 - $39,768	793 Added 5.18%	16,092 $728,000
Q1 2018 May 17, 2018	BUY	$39.6 - $65.9 $235,303 - $391,577	5,942 Added 63.5%	15,299 $739,000
Q4 2017 Feb 13, 2018	BUY	$29.7 - $45.7 $277,902 - $427,614	9,357	9,357 $371,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account